🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Germany / NCT04862507
Recruiting Observational

Improving Low ASPECTS Stroke Thrombectomy

NCT04862507 · tracked via the Priya Life Science Germany tracker
Phase
Observational
Started
2023-05-01
Last updated
2023-05-24

Condition(s) studied

Acute Ischemic Stroke

Investigational drug(s) / intervention(s)

Telephone call on day 90Quantification of lesion water uptake by CT densitometry

Telephone call on day 90: telephone call on day 90 to assess the primary outcome (mRs 90)

Quantification of lesion water uptake by CT densitometry: Retrospective quantification of lesion water uptake by CT densitometry in admission and follow-up imaging

Study summary

Improving Low ASPECTS Stroke Thromectomy (I-LAST) is an academic, independent, prospective, multicenter, observational registry study. Consecutive patients treated with endovascular stroke treatment will be enrolled in German stroke centers. Patients receive regular care and data will be collected as part of clinical routine. Baseline clinical and procedural information as well clinical follow-up information during in-hospital stay, and up to 90 days of stroke onset are collected. Data collected include demographics, National Institute of Health Stroke Scale (NIHSS) on admission, pre-treatment ASPECTS, information on timing and success of interventional treatment, procedural complications, intracranial hemorrhage, and functional outcome. Advanced imaging biomarkers will be tested and validated aiming to improve treatment selection and outcome prediction of patients presenting with extensive baseline infarction.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Clinical diagnosis of acute ischemic stroke * ASPECTS of 0-5 * Confirmed diagnosis of persistent occlusion of terminal carotid artery, middle cerebral artery (M1 or M2), or basilar artery consistent with symptoms * Age \>18 years * Ethic approval in process Exclusion Criteria: none

Primary outcome measure(s)

Trial sites (8)

FacilityCityRegionStatus
Charite University Berlin Berlin Germany Enrolling By Invitation
Hospital Bremen-Mitte Bremen Germany Enrolling By Invitation
University Medical Center Hamburg-Eppendorf Hamburg Germany Recruiting
Westpfalzklinikum Kaiserslautern Germany Enrolling By Invitation
University Hospital Marburg Marburg Germany Recruiting
University Münster Münster Germany Enrolling By Invitation
University Rostock Rostock Germany Enrolling By Invitation
University Basel Basel Switzerland Enrolling By Invitation

More Universitätsklinikum Hamburg-Eppendorf trials in Germany

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04862507 on ClinicalTrials.gov ↗ ← All trials in Germany